Cite
The predictive value of PD‐L1 expression in patients with advanced hepatocellular carcinoma treated with PD‐1/PD‐L1 inhibitors: A systematic review and meta‐analysis.
MLA
Yang, Yao, et al. “The Predictive Value of PD‐L1 Expression in Patients with Advanced Hepatocellular Carcinoma Treated with PD‐1/PD‐L1 Inhibitors: A Systematic Review and Meta‐analysis.” Cancer Medicine, vol. 12, no. 8, Apr. 2023, pp. 9282–92. EBSCOhost, https://doi.org/10.1002/cam4.5676.
APA
Yang, Y., Chen, D., Zhao, B., Ren, L., Huang, R., Feng, B., & Chen, H. (2023). The predictive value of PD‐L1 expression in patients with advanced hepatocellular carcinoma treated with PD‐1/PD‐L1 inhibitors: A systematic review and meta‐analysis. Cancer Medicine, 12(8), 9282–9292. https://doi.org/10.1002/cam4.5676
Chicago
Yang, Yao, Dongbo Chen, Bigeng Zhao, Liying Ren, Rui Huang, Bo Feng, and Hongsong Chen. 2023. “The Predictive Value of PD‐L1 Expression in Patients with Advanced Hepatocellular Carcinoma Treated with PD‐1/PD‐L1 Inhibitors: A Systematic Review and Meta‐analysis.” Cancer Medicine 12 (8): 9282–92. doi:10.1002/cam4.5676.